Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rebecca A. Gladdy, Marielle E. Yohe et al.|Oncogene|2018Cited by 51